Please assess the completion status of the following clinical trial:

Trial Title: A Randomized Controlled Trial of an Antiretroviral Treatment Adherence Intervention for HIV+ African Americans

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* HIV-positive~* 18 years of age or older~* Self-identified as African American/Black~* Been prescribed antiretroviral therapy (ART) in the past 12 months~* Self-reported adherence problems (i.e. missed at least 1 ART dose in the past month) and/or detectable viral load~* Willing to use Medication Events Monitoring System (MEMS) for electronic adherence monitoring.~Exclusion Criteria:~* HIV-negative~* 17 years of age or younger~* Not self-identified as African American/Black, not on antiretroviral therapy (ART) or not prescribed ART therapy in the last than 12 months~* No self-reported adherence problems and/or no detectable viral load~* Not willing to use Medication Events Monitoring System (MEMS) for electronic adherence monitoring.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Rise - Treatment Education (Type: EXPERIMENTAL): Rise consists of a one-month intensive intervention (with three core 60-minute counseling sessions at weeks 1, 2, and 4) followed by two booster sessions (at weeks 12 and 20). If participants show nonadherence during booster sessions, they are offered up to four additional booster sessions (i.e., extra booster sessions if \<85% of prescribed doses were taken in the past month). Thus, participants receive three core sessions in the first month, followed by 2-6 booster sessions over the next four months.
- Control - No Treatment Education (Type: NO_INTERVENTION): The Usual Care control group will only receive standard of care through their HIV clinics.

Based on this trial design, predict the completion outcome and termination type (if applicable).